Rahmé, R., Ades, L., Thomas, X., Guerci-Bresler, A., Pigneux, A., Vey, N., Raffoux, E., Castaigne, S., Spertini, O., Wittnebel, S., Marolleau, J. P., Damaj, G., Bordessoule, D., Lejeune, J., Chevret, S. and Fenaux, P. (2018) “Reducing mortality in newly diagnosed standard-risk acute promyelocytic leukemia in elderly patients treated with arsenic trioxide requires major reduction of chemotherapy: a report by the French Belgian Swiss APL group (APL 2006 trial)”, Haematologica. Pavia, Italy, 103(11), pp. e519-e521. doi: 10.3324/haematol.2018.193151.